InvestorsHub Logo
Followers 33
Posts 2450
Boards Moderated 0
Alias Born 12/10/2015

Re: winna post# 46651

Thursday, 06/04/2020 11:05:53 AM

Thursday, June 04, 2020 11:05:53 AM

Post# of 113799
We have adva27 cancer drug - anyone know when the next update will be on that?

Our licensor, Advanomics Corporation, has developed a way to replace the diester bond with a Carbon-Difluoride bond which acts as a perfect diester isostere. This technology allows us to create a large variety of therapeutic compounds that are completely stable and often more active than the original drugs. This unique capability allowed us to create our Lead Compound, Adva-27a, an effective and highly specific Topoisomerase II (Top2) Inhibitor.

According to Sunshine, Adva-27a has been shown to be effective at killing cells of several cancers—including pancreatic cancer, multidrug resistant breast cancer, small-cell lung cancer, and uterine sarcoma.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News